A few years ago, Richard was diagnosed with prostate cancer. “I never believed I would have cancer,” recalled Richard. “And then to have fatal cancer. Are you kidding me?”
2015 was as an exceptional year for science — in particular, genetics-based science that will directly affect the care and improve the outcome for prostate cancer patients worldwide.
Welcome to the world of precision medicine—where doctors can target each prostate cancer with new, more effective drugs. And this is just the beginning.
We're in the midst of a revolution in how prostate cancer is treated — and it's being led by new knowledge about the genes behind the disease.